0001209191-23-045499.txt : 20230814 0001209191-23-045499.hdr.sgml : 20230814 20230814080009 ACCESSION NUMBER: 0001209191-23-045499 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230811 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WORLAND STEPHEN T CENTRAL INDEX KEY: 0001283307 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39866 FILM NUMBER: 231166382 MAIL ADDRESS: STREET 1: 9050 CAMINO SANTA FE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc. CENTRAL INDEX KEY: 0001828522 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853306396 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 NORTH CEDROS AVENUE, SUITE B CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: (858) 925-8215 MAIL ADDRESS: STREET 1: 142 NORTH CEDROS AVENUE, SUITE B CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER COMPANY: FORMER CONFORMED NAME: Locust Walk Acquisition Corp. DATE OF NAME CHANGE: 20201015 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-11 0 0001828522 eFFECTOR Therapeutics, Inc. EFTR 0001283307 WORLAND STEPHEN T C/O EFFECTOR THERAPEUTICS, INC. 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-08-11 4 M 0 33799 0.52 A 261225 D Common Stock 562339 I By trust Stock Option (Right to Buy) 0.52 2023-08-11 4 M 0 33799 0.00 D 2023-12-16 Common Stock 33799 0 D The stock option vests 25% on December 17, 2014, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. /s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland 2023-08-14